SURREY, BC, March 28, 2019 /CNW/ - NeuroCatch Inc. has received a Health Canada medical device licence for Canada's first and only objective, rapid neuro-physiological brain function assessment system ...
BOSTON, April 9, 2024 /PRNewswire/ -- NeuroCatch Inc., a leading medical device company that enables rapid access to an objective assessment of brain health at the point of care, today announced the ...
- Enhanced Brain Function Assessment System Objectively Evaluates Cognitive Brain Function in Minutes at the Point of Care - BOSTON, MA / ACCESSWIRE / August 2, 2022 / NeuroCatch Inc. ("NCI"), a ...
VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on ...
The NeuroCatch® Platform can be used in various health conditions, including brain injuries, neurological diseases, mental health issues, and brain optimization. SURREY — NeuroCatch Inc., a subsidiary ...
Objective brain function assessment system revolutionizes the ABCs of cognitive function Soon to be available to clinicians and researchers in Canada SURREY, BC, March 28, 2019 /CNW/ - NeuroCatch Inc.
Objective brain function assessment system revolutionizes the ABCs of cognitive function Soon to be available to clinicians and researchers in Canada A wholly owned subsidiary of HealthTech Connex, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback